Pancreatic cancer action network - Join us
Clinical Trial
Finder
Retrieving Trials
Retrieving Trials...

Back to Trial Search

Phase II Study of Olaparib in Patients with Advanced Pancreatic Acinar Cell Carcinoma

Summary

The purpose of this phase II trial is to evaluate the safety and efficacy of Olaparib in patients with advanced pancreatic acinar cell carcinoma.

General Information

NCT#: NCT05286827
Study ID: 10000596
Trial Phase: Phase II

Trial Sponsor: National Cancer Institute (NCI)
Therapies Used in This Trial: Olaparib

Request a Healthcare Provider account to access Trial Eligibility and Site Information.

View Details

An authorized Healthcare Provider account is required to access Trial Eligibility and Site Information. Already have an account?

Request an Account


  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account.
  • In order to view this information, you need to be signed in as a Health Care Provider.
  • In order to see the trial eligibility criteria, you need to be signed in as a Health Care Provider.
  • This information is restricted to validated Health Care Providers.

Eligibility



-------------------------------------------------------------------------------------------

  • In order to view this information, you need to be signed in as a Health Care Provider.
  • You need to be signed in as a Health Care Provider. Please request an account by clicking on the Request button.
  • ------------------------------------------------------------------------------------------------------
  • In order to view this information, you need to be signed in as a Health Care Provider. You are currently not authorized.

Site Information


Back to Trial Search

SHARE THE CLINICAL TRIAL FINDER

JOIN THE CONVERSATION

Privacy Policy
Copyright © 2007–2023 Pancreatic Cancer Action Network

ABOUT US

The Pancreatic Cancer Action Network (PanCAN) is dedicated to fighting the world’s toughest cancer. In our urgent mission to save lives, we attack pancreatic cancer on all fronts: research, clinical initiatives, patient services and advocacy. Our effort is amplified by a nationwide network of grassroots support. We are determined to improve patient outcomes and accelerate progress.

Learn More About Us

Honors & Accreditations

  • Charity Navigator

CONTACT US

No organization supports pancreatic cancer patients like we do. Through our Patient Services, we provide more resources and speak with more patients and caregivers than any other pancreatic cancer organization in the world.

Contact Us